Quick recap going from memory First half was a
Post# of 148175
First half was a rebuttal of the short attack. Second half talked about several things.
1. Some deaths in the serious/critical patients considered a serious adverse event - he didn't talk about this much
2. The have enrolled 120 patients in the serious trial
3. Imminently going to sign a Covid distribution deal with big pharmaceutical
4. Based off of animal data they Think they can cure HIV if they give leronlimab during a stem cell transplant. They've identified 2 patients they want to try this with